Advertisement

A Large Case-series of Successful Treatment of Patients Exposed to Mold and Mycotoxin

      Abstract

      Purpose

      The goal of this study was to present the results of treatment of 100 chemically sensitive and chronically mold-exposed patients, who continued to be disabled even after decontamination of their houses or work places or they were physically removed from their sources of mold.

      Methods

      Molds were identified, serum anti-mold immunoglobulin G antibodies were measured, patients were skin-tested, immunologic abnormalities were recorded, and objective neurologic tests were performed in a subset of patients.

      Findings

      Patient sensitivities and exposures were confirmed by measuring serum immunoglobulin G anti-mold antibodies, intradermal skin testing, and trichothecene toxin breakdown products in the urine. Patients were positive (44%–98%) for individual molds. Abnormalities in T and B cells were found in >80% of patients. Respiratory signs were present in 64% of all patients, and physical signs and symptoms of neurologic dysfunction were present in 70%. Objective autonomic nervous system test results were abnormal in almost 100% of patients tested. Objective neuropsychological evaluations were conducted in 46 of the patients who exhibited symptoms of neurologic impairment and showed typical abnormalities in short-term memory, executive function/judgment, concentration, and hand/eye coordination. Patients (N = 100) with documented mold exposure were divided into 3 groups: (1) those who improved easily, with mold avoidance and antigen injections; (2) those who improved after desensitization to their mold antigens plus additional mycotoxin antigens; and (3) those who had their regular mold antigens, additional mycotoxin antigens, along with regimens that included sauna, oxygen therapy, and nutrients. Approximately 85% of all patients cleared completely; 14% had partial improvement, and 1% remained unchanged.

      Implications

      Exposure to molds has been increasingly recognized as a major reason for patients presenting with multiple organ symptoms that could not otherwise be explained. Early diagnosis and appropriate treatment could be very successful.

      Key words

      To read this article in full you will need to make a payment
      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lieberman A.
        • Rea W.
        • Curtis L.
        Adverse health effects of indoor mold exposure.
        J Allergy Clin Immunol. 2006; 118: 763
        • Pasanen A.
        A review. Fungal exposure assessment in indoor environments.
        Indoor Air. 2001; 11: 87-98
        • Dillion H.K.
        • Miller J.D.
        • Soreson W.G.
        • et al.
        Review of methods applicable to the assessment of mold exposure in children.
        Environment Health Prespective. 1999; 107: 473-480
        • Rea W.J.
        Chemical Sensitivity: Principles and Mechanisms. Lewis Publishers, Boca Raton, FL1992: 19 (Vol. I)
        • Rea W.J.
        Chemical Sensitivity: Sources of Total Body Load. Lewis Publishers, Boca Raton, FL1994: 1017-1039 (Vol. II)
      1. American Industrial Hygiene Association (AIHA): “Facts about Mold.” December 2011. http://www.aiha.org/newspubs/newsroom/Documents/Facts%20About%20Mold%20December%202011.pdf.

        • Rea W.J.
        • Didriksen N.
        • Simon T.R.
        • et al.
        Effects of toxic exposure to molds and mycotoxins in building-related illnesses.
        Arch Environm Health. 2003; 58: 399-405
        • Vojdani A.
        • Campbell A.W.
        • Kashanian A.
        • et al.
        Antibodies against molds and mycotoxins following exposure to toxigenic fungi in a water-damaged building.
        Arch Environ Health. 2003; 58: 324-336
        • Rinkel H.J.
        Inhalant allergy. Part I: the whealing response of the skin to serial dilution testing.
        Ann Allergy. 1949; 7: 625-630
        • Croft W.A.
        • Jastromski B.M.
        • Croft A.L.
        • et al.
        Clinical confirmation of trichothecene mycotoxicosis in patient urine.
        J Environ Biol. 2002; 23: 301-320
        • Popi V.
        Cell-mediated immunity in asthma.
        Am J Respir Crit Care Med. 2002; 166: 1607
        • Ishikawa S.
        • Natio M.
        • Inabe K.L.
        A new video pupillography.
        Ophthalmologica. 1970; 160: 248
        • Terechtchenko L.
        • Doronina S.A.
        • Pochinok E.M.
        • Riftine A.
        Autonomic tone in patients with supraventricular arrhythmia associated with mitral valve prolapse in young men.
        Pacing Clin Electrophysiol. 2003; 26: 444-446
        • Gray M.R.
        • Thrasher J.D.
        • Crago R.
        • et al.
        Mixed mold myco­toxicosis: immunological changes in humans following exposure in water-damaged buildings.
        Arch Environ Health. 2003; 58: 390-398
        • Rea W.J.
        Reviews on Environmental Health: History of Chemical Sensitivity and Diagnosis.
        De Gruyter, Berlin, Germany2016
        • Randolph T.G.
        Human Ecology and Susceptibility to the Chemical Environment.
        C.C. Thomas, Springfield, IL1962
        • Rea W.J.
        Chemical Sensitivity: Principles and Mechanisms. Vol. I. Lewis Publishers, Boca Raton, FL1992: 19 (Vol. I)
        • Rea W.J.
        Chemical Sensitivity: Tools of Diagnosis and Methods of Treatment. Vol. IV. Lewis Publishers, Boca Raton, FL1997: 2541 (Vol. IV)
        • Rea W.J.
        Chemical Sensitivity: Tools of Diagnosis and Methods of Treatment. Vol. IV. Lewis Publishers, Boca Raton, FL1997: 2433 (Vol. IV)
        • Rea W.J.
        Chemical Sensitivity: Tools of Diagnosis and Methods of Treatment. Vol. IV. Lewis Publishers, Boca Raton, FL1997: 2554-2563 (Vol. IV)
        • Rea W.J.
        • Pan Y.
        • Griffiths B.
        The treatment of patients with mycotoxin-induced disease.
        Toxicol Ind Health. 2009; 25: 711-714
        • Hooper D.G.
        • Bolton V.E.
        • Guilford F.T.
        • Straus D.C.
        Mycotoxin detection in human samples from patients exposed to environmental molds.
        Int J Mol Sci. 2009; 10: 1465-1475
        • Kilburn K.H.
        Indoor mold exposure associated with neurobehavioral and pulmonary impairment: a preliminary report.
        Arch Environ Health. 2003; 58: 390-398